Micrornas in drug-induced liver injury

21Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Drug-induced liver injury (DILI) is a leading cause of acute liver failure, and a major reason for the recall of marketed drugs. Detection of potential liver injury is a challenge for clinical management and preclinical drug safety studies, as well as a great obstacle to the development of new, effective and safe drugs. Currently, serum levels of alanine and aspartate aminotransferases are the gold standard for evaluating liver injury. However, these levels are assessed by nonspecific, insensitive, and non-predictive tests, and often result in false-positive results. Therefore, there is an urgent need for better DILI biomarkers to guide risk assessment and patient management. The discovery of microRNAs (miRNAs) as a new class of gene expression regulators has triggered an explosion of research, particularly on the measurement of miRNAs in various body fluids as biomarkers for many human diseases. The properties of miRNA-based biomarkers, such as tissue specificity and high stability and sensitivity, suggest they could be used as novel, minimally invasive and stable DILI biomarkers. In the current review, we summarize recent progress concerning the role of miRNAs in diagnosing and monitoring both clinical and preclinical DILI, and discuss the main advantages and challenges of miRNAs as novel DILI biomarkers.

References Powered by Scopus

MicroRNAs: Genomics, Biogenesis, Mechanism, and Function

32013Citations
N/AReaders
Get full text

MicroRNAs: Target Recognition and Regulatory Functions

17471Citations
N/AReaders
Get full text

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

10778Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Micrornas as biomarkers for liver disease and hepatocellular carcinoma

170Citations
N/AReaders
Get full text

Drug induced liver injury: Can biomarkers assist RUCAM in causality assessment?

50Citations
N/AReaders
Get full text

Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method

47Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, L. M., Wang, D., & Zen, K. (2014). Micrornas in drug-induced liver injury. Journal of Clinical and Translational Hepatology. Xia and He Publishing Inc. https://doi.org/10.14218/JCTH.2014.00015

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

67%

Researcher 5

21%

Professor / Associate Prof. 3

13%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 8

32%

Agricultural and Biological Sciences 7

28%

Medicine and Dentistry 6

24%

Pharmacology, Toxicology and Pharmaceut... 4

16%

Save time finding and organizing research with Mendeley

Sign up for free